Published in Eur Radiol on September 20, 2007
Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol (2009) 1.24
High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer? Eur Radiol (2011) 0.95
Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T. Eur Radiol (2013) 0.90
Identification of Breast Cancer Using Integrated Information from MRI and Mammography. PLoS One (2015) 0.79
Adjacent vessel sign and breast imaging reporting and data system are valuable for diagnosis of benign and malignant breast lesions. Biotechnol Biotechnol Equip (2014) 0.77
3.0 Tesla breast magnetic resonance imaging in patients with nipple discharge when mammography and ultrasound fail. Eur Radiol (2014) 0.77
Assessment of Semiquantitative Parameters of Dynamic Contrast-Enhanced Perfusion MR Imaging in Differentiation of Subtypes of Renal Cell Carcinoma. Pol J Radiol (2016) 0.77
Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging. Eur Radiol (2014) 0.76
Bilateral analysis of the cross-sectional area of the internal mammary arteries and veins in patients with and without breast cancer on breast magnetic resonance imaging. Insights Imaging (2013) 0.75
Breast Contrast Enhanced MR Imaging: Semi-Automatic Detection of Vascular Map and Predominant Feeding Vessel. PLoS One (2016) 0.75
Extramammary findings on breast MRI: prevalence and imaging characteristics favoring malignancy detection: a retrospective analysis. World J Surg Oncol (2016) 0.75
A novel functional infrared imaging system coupled with multiparametric computerised analysis for risk assessment of breast cancer. Eur Radiol (2012) 0.75
MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med (2007) 10.28
Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology (2006) 3.40
Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg (2004) 2.57
Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol (2006) 2.44
Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology (1999) 2.11
Breast MR imaging: interpretation model. Radiology (1997) 2.07
Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging (2001) 1.89
Breast disease: dynamic spiral MR imaging. Radiology (1998) 1.89
MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol (2003) 1.84
Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging (1999) 1.81
Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology (2004) 1.73
Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology (2005) 1.57
Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol (2000) 1.55
Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics (2006) 1.48
MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology (1993) 1.46
Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology (1994) 1.46
MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology (1994) 1.32
Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology (1995) 1.11
Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol (2006) 1.07
Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am (2001) 1.02
Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol (1996) 0.96
Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol (2000) 0.93
Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology (2005) 0.91
Value of 1.0- M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol (2002) 0.91
Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience. J Magn Reson Imaging (2003) 0.89
Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity? Eur Radiol (2001) 0.86
Increased ipsilateral whole breast vascularity as measured by contrast-enhanced magnetic resonance imaging in patients with breast cancer. Am J Surg (2005) 0.85
Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography. Eur Radiol (2006) 0.83
Maximum intensity projection analysis in magnetic resonance of the breast. J Exp Clin Cancer Res (2002) 0.82
MR imaging of the breast: indications, established technique, and new directions. Eur Radiol (2003) 0.82
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 4.27
Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat (2012) 3.99
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol (2001) 3.94
Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol (2000) 3.20
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol (2005) 2.70
Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer (1993) 2.60
Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma (2001) 2.39
Doxorubicin gradients in human breast cancer. Clin Cancer Res (1999) 2.36
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol (2001) 2.33
Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol (2005) 2.10
Radioactive seed localization for non-palpable breast cancer. Br J Surg (2013) 2.07
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol (2000) 2.04
Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg (1998) 2.02
Reduced local immune response with continuous positive airway pressure during one-lung ventilation for oesophagectomy. Br J Anaesth (2014) 1.98
[Possible treatments for patients with symptomatic carotid artery stenosis]. Ned Tijdschr Geneeskd (2005) 1.92
Relationships between vascularization and proliferation in invasive breast cancer. J Pathol (1999) 1.90
Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy. Eur Radiol (2011) 1.89
Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood (1997) 1.82
[The sentinel node procedure: standard intervention for surgical treatment of breast cancer]. Ned Tijdschr Geneeskd (1998) 1.76
Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest (1995) 1.75
Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg (2014) 1.75
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol (2008) 1.69
Interstitial laser coagulation for hepatic tumours. Br J Surg (1999) 1.68
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol (1998) 1.62
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. Histopathology (2003) 1.59
Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol (1996) 1.58
Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol (1998) 1.58
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene (2007) 1.57
Comparative genomic hybridisation. Mol Pathol (1999) 1.56
The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost (2003) 1.55
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
Clinical and genetic evaluation of thirty ovarian cancer families. Am J Obstet Gynecol (1998) 1.49
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells. Eur J Cancer (2003) 1.48
Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology (2005) 1.47
Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants. Heart (2009) 1.45
Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol (1999) 1.45
Transhiatal robot-assisted esophagectomy. Surg Endosc (2008) 1.44
In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol (2008) 1.42
Impactitis: new cures for an old disease. J Clin Pathol (2001) 1.42
Histopathology of fibroadenoma of the breast. Am J Clin Pathol (2001) 1.41
[Increased perioperative blood loss during treatment with paroxetine]. Ned Tijdschr Geneeskd (2002) 1.40
DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol (2007) 1.40
[MRI-guided biopsy of suspicious abnormalities in the breast]. Ned Tijdschr Geneeskd (2006) 1.38
Quality control methods for data entry in pathology using a computerized data management system based on an extended data dictionary. Hum Pathol (1992) 1.38
[Primary adenocarcinoma of the small intestine]. Ned Tijdschr Geneeskd (2003) 1.37
Frequency and outcome of pulmonary polymethylmethacrylate embolism during percutaneous vertebroplasty. AJNR Am J Neuroradiol (2008) 1.36
Robot-assisted thoracoscopic oesophagectomy for cancer. Br J Surg (2009) 1.36
Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol (2005) 1.35
Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg (2001) 1.34
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34
Percutaneous vertebroplasty and pulmonary cement embolism: results from VERTOS II. AJNR Am J Neuroradiol (2010) 1.33
Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol (1994) 1.31
Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol (1999) 1.28
Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg (2000) 1.27
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol (2001) 1.26
Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med (1997) 1.25
Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol (1999) 1.25
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer (2001) 1.25
Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol (2004) 1.25
Vacuum-assisted breast biopsy: a critical review. Eur J Cancer (2003) 1.24
Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol (2006) 1.24
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer (1998) 1.23
Molecular imaging of breast cancer. Breast (2009) 1.22
Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res (2000) 1.21
'Radioguided occult lesion localisation' (ROLL) for non-palpable breast lesions: a review of the relevant literature. Eur J Surg Oncol (2007) 1.21
Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol (2009) 1.20
Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directions. Eur Radiol (2008) 1.19
Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer (2010) 1.19
Prevalence and clinical consequences of carotid artery residual defects following endarterectomy: a prospective CT angiography evaluation study. Eur J Vasc Endovasc Surg (2011) 1.19
Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions. Br J Cancer (2004) 1.18
Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene (2006) 1.17
Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2001) 1.16
Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol (2000) 1.16
European survey on the application of vascular clamping in liver surgery. Dig Surg (2007) 1.14
Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol (2011) 1.14
5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B (1998) 1.14
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci (2001) 1.13
Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol (1995) 1.13
Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann Oncol (2008) 1.12
Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol (2011) 1.12
Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology (2000) 1.10
Histopathology of retrieved allografts of the femoral head. J Bone Joint Surg Br (1999) 1.10
Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol (1997) 1.10
Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy. Br J Cancer (2004) 1.10